Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 369
Titolo Tipologia Data di pubblicazione Autori File
Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: Subgroup analyses from the phase 4 BYOND study 01 - Articolo su rivista 2024 Gambacorti-Passerini C. +
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 01 - Articolo su rivista 2024 Villa, MatteoSharma, Geeta G.Malighetti, FedericaMauri, MarioCordani, NicolettaPirola, AlessandraD'Aliberti, DeborahMassimino, LucaCriscuolo, LucreziaPagani, LisaChinello, CliziaMastini, CristinaFontana, DilettaBombelli, SilviaMeneveri, RaffaellaMagni, FulvioUrso, MarioPagni, FabioRamazzotti, DanielePiazza, RoccoGambacorti-Passerini, CarloMologni, Luca +
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 01 - Articolo su rivista 2024 Malighetti, FedericaVilla, MatteoMauri, MarioPiane, SimoneCrippa, ValentinaCrespiatico, IlariaCocito, FedericaBossi, ElisaSteidl, CarolinaCivettini, IvanScollo, ChiaraRamazzotti, DanieleGambacorti-Passerini, CarloPiazza, RoccoMologni, LucaAroldi, Andrea
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 01 - Articolo su rivista 2024 Crespiatico I.Mastini C.D'Aliberti D.Mauri M.Mercado C. M.Fontana D.Spinelli S.Crippa V.Inzoli E.Manghisi B.Civettini I.Ramazzotti D.Sangiorgio V.Brambilla V.Aroldi A.Barone C.Orsenigo R.Serafini M.Mottadelli F.Cazzaniga G.Pagni F.Azzoni E.Gambacorti Passerini C.Elli E. M.Mologni L.Piazza R. +
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making 01 - Articolo su rivista 2024 Civettini, IvanZappaterra, AriannaGranelli, Bianca MariaRindone, GiovanniAroldi, AndreaBonfanti, StefanoColombo, FedericaFedele, MarilenaPerfetti, PaolaTerruzzi, ElisabettaGambacorti-Passerini, CarloRamazzotti, DanieleCavalca, Fabrizio +
Impact of age and comorbidities on the efficacy and tolerability of bosutinib in previously treated patients with chronic myeloid leukemia: results from the phase 4 BYOND study 01 - Articolo su rivista 2024 Gambacorti-Passerini C. +
Author Correction: The evolutionary history of 2,658 cancers (Nature, (2020), 578, 7793, (122-128), 10.1038/s41586-019-1907-7) 99 - Altro 2023 Gambacorti-Passerini C. +
Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes (Nature, (2020), 578, 7793, (102-111), 10.1038/s41586-020-1965-x) 99 - Altro 2023 Gambacorti-Passerini C. +
Author Correction: The repertoire of mutational signatures in human cancer (Nature, (2020), 578, 7793, (94-101), 10.1038/s41586-020-1943-3) 99 - Altro 2023 Gambacorti-Passerini C. +
Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition (Nature Genetics, (2020), 52, 3, (306-319), 10.1038/s41588-019-0562-0) 99 - Altro 2023 Gambacorti-Passerini C. +
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing (Nature Genetics, (2020), 52, 3, (331-341), 10.1038/s41588-019-0576-7) 99 - Altro 2023 Gambacorti-Passerini C. +
Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes (Nature Biotechnology, (2020), 38, 3, (288-292), 10.1038/s41587-019-0360-3) 99 - Altro 2023 Gambacorti-Passerini C. +
Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (Nature Genetics, (2020), 52, 3, (294-305), 10.1038/s41588-019-0564-y) 99 - Altro 2023 Gambacorti-Passerini C. +
Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x) 99 - Altro 2023 Gambacorti-Passerini C. +
Author Correction: The landscape of viral associations in human cancers (Nature Genetics, (2020), 52, 3, (320-330), 10.1038/s41588-019-0558-9) 99 - Altro 2023 Gambacorti-Passerini C. +
Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers (Nature Genetics, (2020), 52, 3, (342-352), 10.1038/s41588-019-0557-x) 99 - Altro 2023 Gambacorti-Passerini C. +
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis 02 - Intervento a convegno 2023 Crespiatico, IlariaMastini, CristinaD'Aliberti, DeborahMauri, MarioMercado, Carl MirkoFontana, DilettaSpinelli, SilviaCrippa, ValentinaInzoli, ElenaManghisi, BeatriceCivettini, IvanRamazzotti, DanieleGengotti, MicheleBrambilla, VirginiaAroldi, AndreaBarone, CristianaOrsenigo, RobertoSerafini, MartaCazzaniga, GiovanniPagni, FabioAzzoni, EmanueleGambacorti-Passerini, CarloElli, Elena MariaMologni, LucaPiazza, Rocco +
DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients 01 - Articolo su rivista 2023 Malighetti, FedericaMauri, MarioVilla, MatteoManghisi, BeatriceInzoli, ElenaRindone, GiovanniCivettini, IvanGuglielmana, VeronicaRamazzotti, DanieleBombelli, SilviaPerego, RobertoPiazza, RoccoMologni, LucaGambacorti-Passerini, Carlo +
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 01 - Articolo su rivista 2023 Aroldi, AMauri, MRamazzotti, DVilla, MMalighetti, FCrippa, VCocito, FBorella, CBossi, ESteidl, CScollo, CMologni, LPiazza, RGambacorti Passerini, C +
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 01 - Articolo su rivista 2023 Rindone, GiovanniAroldi, AndreaBossi, ElisaVerga, LuisaZambrotta, GiovanniTarantino, SaraPiazza, RoccoGambacorti-Passerini, Carlo +
Mostrati risultati da 21 a 40 di 369
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile